FDA 483 - United Exchange Corp. - April 06, 2018

An FDA inspection of United Exchange Corp., a pharmaceutical warehouse and importer in Rialto, CA, revealed two significant observations. The firm's sampling plan for incoming drug products was found to be unrepresentative and samples were not properly identified. Additionally, the facility lacked adequate segregation and identification methods for quarantined drug products, storing them alongside released products.